Infections
Sinusitis is the inflammation of the paranasal sinuses that can be classified as acute (<4 weeks), subacute (4-12 weeks), or chronic (>12 weeks). Management involves symptomatic relief, addressing underlying causes, and targeted antimicrobial therapy when bacterial infection is confirmed or strongly suspected.
🎯 Understanding Sinusitis Classification
Differentiating acute and chronic sinusitis is critical for appropriate management:
🔥 Acute Sinusitis
- Duration: <4 weeks of symptoms
- Common causes: Viral (most common: 90-98%), bacterial, fungal
- Bacterial pathogens: S. pneumoniae, H. influenzae, M. catarrhalis
- Presentation: Purulent nasal discharge, facial pain/pressure, fever
- Diagnostic criteria: ≥10 days without improvement OR severe onset
- Treatment: Symptomatic first; antibiotics if bacterial confirmed
- Key Point: MOST are viral - antibiotics ONLY for bacterial cases
📈 Chronic Sinusitis
- Duration: >12 weeks of persistent symptoms
- Types: CRS with nasal polyps (CRSwNP), CRS without nasal polyps (CRSsNP)
- Pathophysiology: Persistent inflammation, often multifactorial (allergy, anatomy, immune)
- Presentation: Nasal obstruction, discolored drainage, reduced smell (anosmia)
- Diagnosis: Symptoms + objective evidence (CT scan, endoscopy)
- Treatment: Comprehensive management including corticosteroids, irrigation
- Key Point: CHRONIC inflammatory condition requiring long-term management
🎯 Clinical Memory Aid: Remember "Duration Defines Treatment"
- <4 weeks: Acute → Symptomatic ± antibiotics if bacterial
- 4-12 weeks: Subacute → Continue symptomatic, reassess
- >12 weeks: Chronic → Comprehensive inflammatory management
💊 Symptomatic Management
Medications for symptom relief in both acute and chronic sinusitis (FIRST-LINE for all cases):
🧂 Nasal Saline Irrigation
- Mechanism: Mechanical clearance of mucus, allergens, irritants
- Forms: Isotonic (0.9%) or hypertonic (2-3%) saline solutions
- Benefits: Improves mucociliary clearance, reduces edema, thins secretions
- Frequency: Acute: 2-4 times daily; Chronic: 1-2 times daily maintenance
- Evidence: Strong for both acute and chronic sinusitis (Grade A recommendation)
- Key Point: Foundation of sinusitis management - start ALL patients here
💊 Intranasal Corticosteroids (INCS)
- Examples: Fluticasone, Mometasone, Budesonide
- Mechanism: Reduce mucosal inflammation, edema, and polyp size
- Onset: Several days to achieve full effect (2-4 weeks for polyps)
- Duration: Acute: 2-3 weeks; Chronic: long-term maintenance
- Side Effects: Nasal irritation, epistaxis (nosebleeds), headache
- Key Point: First-line for chronic sinusitis; adjunct for acute
🌡️ Decongestants
- Topical: Oxymetazoline, Phenylephrine (MAX 3-5 days)
- Oral: Pseudoephedrine, Phenylephrine
- Mechanism: Vasoconstriction reduces nasal congestion
- Risks: Rebound congestion (rhinitis medicamentosa), hypertension, insomnia
- Duration: Short-term use only for acute severe symptoms
- Key Point: AVOID prolonged topical use - causes worse congestion
🤒 Analgesics & Supportive Care
- Pain relief: Acetaminophen, NSAIDs (ibuprofen) for facial pain/headache
- Mucolytics: Guaifenesin may help thin secretions (weak evidence)
- Antihistamines: Only if allergic component confirmed (sedating types worsen dryness)
- Steam inhalation: Provides symptomatic relief, humidifies airways
- Hydration: Adequate fluid intake essential for mucus hydration
- Key Point: Address specific symptoms; avoid unnecessary medications
⚠️ CRITICAL WARNING: Topical decongestant overuse (>5-7 days) causes rhinitis medicamentosa - severe rebound congestion worse than original symptoms. Patients become dependent. Educate: "3 days on, 3 days off" maximum.
🦠 Antibiotic Therapy
Targeted antimicrobial treatment for bacterial sinusitis (use judiciously - most sinusitis is viral):
⚡ When to Use Antibiotics
- ≥10 days without improvement: Symptoms persistent or worsening
- Severe symptoms: High fever (>39°C/102°F), purulent discharge, severe facial pain ≥3-4 days
- Double-worsening: Initial improvement then worsening (bacterial superinfection)
- Immunocompromised patients: Lower threshold for treatment
- Complications present: Orbital/intracranial involvement
- Key Point: 90-98% of acute sinusitis is VIRAL - antibiotics not indicated
👁️ When to Observe (No Antibiotics)
- Mild-moderate symptoms <10 days: Likely viral
- No severe features: No high fever, severe pain, systemic symptoms
- Patient preference: With safety-net prescription if available
- Low-risk patient: Healthy, no comorbidities
- Good follow-up: Can return if worsening
- Key Point: Observation appropriate for majority of acute sinusitis cases
💊 First-line Antibiotic Choices
- Amoxicillin-clavulanate: 875/125 mg BID or 2000/125 mg BID (high-dose) for 5-7 days Preferred due to β-lactamase coverage for H. influenzae and M. catarrhalis
- Amoxicillin: 500 mg TID or 875 mg BID for 5-7 days Only in low-resistance areas or mild cases
- Doxycycline: 100 mg BID for 5-7 days (penicillin allergy) Good S. pneumoniae coverage, not for children <8 years
- Duration: Typically 5-7 days for acute; 10-14 days if chronic exacerbation Shorter courses effective; longer if immunocompromised or severe
- Pediatric dosing: Amoxicillin-clavulanate 45 mg/kg/day divided BID High-dose for resistant S. pneumoniae
🚨 ANTIBIOTIC STEWARDSHIP CRITICAL:
- Most acute sinusitis is viral (90-98%) - avoid unnecessary antibiotics
- Use strict clinical criteria to distinguish viral from bacterial
- Consider watchful waiting for mild-moderate cases with safety-net Rx
- Reserve broader-spectrum antibiotics for true treatment failures
- Follow local resistance patterns for appropriate antibiotic selection
- Educate patients: Expected course 10-14 days; antibiotics only shorten by 1-2 days
📊 Antibiotic Selection Guide
| Clinical Scenario | First-line Therapy | Alternative Options | Duration | Special Considerations |
|---|---|---|---|---|
| Uncomplicated Acute Bacterial Sinusitis (Adult) |
Amoxicillin-clavulanate 875/125 mg BID | Doxycycline 100 mg BID Levofloxacin 500 mg daily |
5-7 days | Amoxicillin alone only in low resistance areas |
| Penicillin Allergy (non-severe) |
Doxycycline 100 mg BID | Levofloxacin 500 mg daily Cefuroxime 500 mg BID |
5-7 days | Assess true penicillin allergy (90% not allergic) |
| Treatment Failure (after 72 hours) |
High-dose Amox-Clav 2000/125 mg BID | Respiratory FQ (Levo/Moxi) Clindamycin + Cefixime |
7-10 days | Consider sinus culture, reassess diagnosis |
| Chronic Sinusitis Exacerbation | Culture-directed therapy | Broad-spectrum (include Pseudomonas coverage if recurrent) | 10-14 days | Often needs ENT referral for culture |
| Pediatric Sinusitis (2-12 years) |
Amox-Clav 45 mg/kg/day div BID | Cefdinir 14 mg/kg/day Cefuroxime 30 mg/kg/day |
10-14 days | Avoid tetracyclines (<8 yrs), FQs (reserve) |
🔥 HIGH-YIELD: Antibiotic Pearls for Sinusitis
- Amoxicillin-clavulanate preferred over amoxicillin alone (β-lactamase coverage)
- 5-7 day courses effective (not 10-14 days as previously taught)
- Doxycycline excellent choice for penicillin allergy (covers S. pneumoniae well)
- Fluoroquinolones (Levofloxacin) reserved for failures/allergies (black box warnings)
- Pediatrics: Higher doses needed (45 mg/kg/day amoxicillin component)
🌿 Comprehensive Chronic Sinusitis Management
Multimodal approach for persistent sinus inflammation (requires long-term strategy):
🩺 Medical Management Strategies
- High-volume saline irrigation: Daily maintenance therapy Neti pot or squeeze bottle; reduces symptoms 30-50%
- Intranasal corticosteroids (INCS): Long-term control of inflammation Continuous use; 4-6 weeks to see full polyp reduction effect
- Short-course oral corticosteroids: For severe exacerbations or polyps Prednisone 0.5 mg/kg/day x 5-7 days then taper; monitor side effects
- Leukotriene modifiers: Montelukast for allergic component Especially helpful in AERD (aspirin-exacerbated respiratory disease)
- Antihistamines: For documented allergic rhinitis component Second-generation preferred (less sedation, drying)
- Long-term macrolides: Low-dose for anti-inflammatory effects Azithromycin 250 mg 3x/week; 12-week trial; monitor for resistance
🏥 Advanced & Surgical Therapies
- Biologics: Dupilumab for severe CRSwNP refractory to surgery Anti-IL-4/IL-13; reduces polyp size, improves smell; expensive
- Allergen immunotherapy: If specific allergens identified SLIT (sublingual) or SCIT (subcutaneous); 3-5 year commitment
- Aspirin desensitization: For AERD (aspirin-exacerbated respiratory disease) Specialized procedure; maintains desensitization with daily aspirin
- Surgical referral: For failed medical management (≥3 months) Functional endoscopic sinus surgery (FESS); not curative, improves medication delivery
- Multidisciplinary care: Allergy, ENT, pulmonology collaboration Essential for complex cases, comorbidities (asthma, COPD)
🔍 CRITICAL CLINICAL INSIGHT: Chronic sinusitis requires a "treat-to-target" approach similar to other chronic inflammatory conditions (like rheumatoid arthritis). Regular assessment of symptom control (SNOT-22 questionnaire), quality of life measures, and objective findings (endoscopy) guides therapy escalation. Patient education about the chronic nature of the condition and adherence to maintenance therapy is crucial for long-term success.
Mnemonic: "CRS = Chronic Requires Systematic" management
Mnemonic: "CRS = Chronic Requires Systematic" management
⚠️ Special Considerations & Complications
Management considerations for specific scenarios and emergency situations:
📉 Pediatric Sinusitis
- Diagnosis challenges: Symptoms overlap with viral URIs (common in children)
- Antibiotic selection: Amoxicillin or amoxicillin-clavulanate first-line
- Avoid: Tetracyclines in children <8 years (tooth staining), fluoroquinolones (tendon risk)
- Adjunctive therapy: Saline irrigation (age-appropriate), intranasal corticosteroids
- Follow-up: Close monitoring for complications (more common in children)
- Key Point: More conservative with antibiotics; shorter courses often sufficient
🚨 RED FLAGS REQUIRING IMMEDIATE ATTENTION:
- Severe headache: Especially with meningeal signs (neck stiffness, photophobia)
- Visual changes: Diplopia (double vision), decreased vision, proptosis (eye bulging)
- Periorbital edema: With erythema (redness) and fever (orbital cellulitis)
- Neurological symptoms: Altered mental status, focal deficits, seizures
- High fever: With toxic appearance (sepsis concern)
- Frontal swelling: Especially in adolescents (Pott's puffy tumor)
- ACTION: Emergency evaluation, CT/MRI imaging, ENT/ophthalmology/neurosurgery consult
🎯 Prevention Strategies
Evidence-based approaches to reduce sinusitis incidence and recurrence:
💉 Primary Prevention
- Vaccination: Pneumococcal, annual influenza vaccines Reduces bacterial superinfections after viral URIs
- Allergen avoidance: Dust mites, mold, pet dander if allergic HEPA filters, mattress covers, humidity control (<50%)
- Hand hygiene: Reduces viral URI transmission Most sinusitis starts as viral URI
- Smoke avoidance: Eliminate tobacco and secondhand smoke Damages mucociliary clearance
🛡️ Secondary Prevention
- Early saline irrigation: At first URI symptoms Prevents sinus ostia obstruction
- Proper nasal steroid use: During allergy seasons Prevents allergic inflammation progression
- Humidification: Dry air worsens symptoms Especially in winter with indoor heating
- Identify triggers: Allergy testing, environmental controls Prevent recurrent episodes
📋 Tertiary Prevention
- Maintenance therapy: Daily saline, regular INCS for chronic cases Prevents exacerbations
- Surgical correction: Anatomical abnormalities (deviated septum, polyps) Improves drainage, medication delivery
- Immunotherapy: For confirmed allergic triggers Alters immune response long-term
- Regular follow-up: ENT monitoring for chronic cases Early detection of complications
🩺 VACCINE IMPACT: Since introduction of pneumococcal conjugate vaccine (PCV):
- Pediatric sinusitis: Reduced incidence of bacterial complications
- PCV serotypes: Dramatic reduction in vaccine-type pneumococcal sinusitis
- Serotype replacement: Some increase in non-vaccine serotypes (19A, 35B)
- Antibiotic resistance: Reduction in penicillin-resistant S. pneumoniae
- Influenza vaccine: Reduces viral URIs that predispose to bacterial sinusitis
🧠 Key Pharmacologic Principles
Essential considerations for understanding and managing sinusitis:
🎯 CLINICAL DECISION ALGORITHM:
- Step 1: Determine duration → Acute (<4w) vs Chronic (>12w)
- Step 2: ALL patients start with saline irrigation + symptomatic care
- Step 3: For acute: Assess bacterial vs viral:
- ≥10 days no improvement → Consider antibiotics
- Severe onset → Consider antibiotics
- Double-worsening → Consider antibiotics
- Otherwise → Observe, supportive care
- Step 4: First-line antibiotic: Amoxicillin-clavulanate 5-7 days
- Step 5: For chronic: Add INCS long-term, consider underlying causes
- Step 6: Refer if: Treatment failure, complications, or surgical consideration
⚠️ COMMON PITFALLS TO AVOID:
- Antibiotics for viral sinusitis: 90-98% are viral - unnecessary
- Topical decongestant overuse: Causes rebound congestion (rhinitis medicamentosa)
- Missing chronic sinusitis: Treating as repeated acute episodes
- Ignoring allergies: Uncontrolled allergies perpetuate sinusitis
- Inadequate saline instruction: Patients need proper technique demonstration
- Overlooking complications: Know red flags requiring urgent referral
🧭 Conclusion
Effective management of sinusitis requires precise differentiation between acute viral, acute bacterial, and chronic inflammatory forms. Most acute sinusitis (90-98%) is viral and requires only symptomatic management with saline irrigation, analgesics, and time. Antibiotics should be reserved for cases meeting specific criteria: symptoms ≥10 days without improvement, severe onset, or double-worsening pattern.
For acute bacterial sinusitis, amoxicillin-clavulanate remains first-line therapy, with doxycycline as an excellent alternative for penicillin-allergic patients. Short courses (5-7 days) are typically effective, aligning with antimicrobial stewardship principles to reduce resistance.
Chronic sinusitis represents a distinct entity requiring long-term inflammatory control with daily saline irrigation, intranasal corticosteroids, and attention to underlying factors such as allergies, anatomy, and immune function. Advanced therapies including biologics (dupilumab) and surgery (FESS) play important roles in refractory cases.
Prevention strategies focus on vaccination, allergen avoidance, and proper management of predisposing conditions. Recognition of complication red flags - particularly orbital and intracranial extensions - ensures timely intervention for potentially life-threatening situations.
Sinusitis management balances therapeutic restraint with timely intervention — most cases need only saline and time, but recognizing the few that need antibiotics or specialist care prevents both overtreatment and complications. This nuanced approach preserves antibiotic effectiveness while ensuring optimal patient outcomes across the spectrum of sinus inflammatory disease.